Clinical Trial Update: Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating F-18 FDG biokinetics in pediatric molecular imaging has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Neoplasm

Snippet

Sponsor: Boston Children's Hospital | Conditions: Childhood Neoplasm | Phase 4 | Status: WITHDRAWN